Clinical trial
Randomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip Disease
NCT03112785 is registered in ClinicalTrials.gov with Sahlgrenska University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Comparison Between the Fitmore and the CLS Stem in Patients Operated in One-stage Due to Bilateral Symptomatous Hip Disease
- Lead sponsor
- Sahlgrenska University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 17, 2011
- Completion date
- June 30, 2026
- Enrollment
- 44 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bilateral hip disease, primary hip osteoarthritis, secondary hip osteoarthritis due to idiopathic femoral head necrosis, childhood or inflammatory disease, surgical treatment